Wow cool, thanks. So Biotech has its own rules in HKEX.On a philosophical note, if the wholly owned subsidiary is worth US $200M -- how can the parent not be worth much more?
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game